Legal Opinion
Supernus Pharmaceuticals, Inc. v. Iancu
Court of Appeals for the Federal Circuit
Decided January 23, 2019No. 2017-1357PublishedCited by 17 opinions
1Opinion of the Court
Reyna, Circuit Judge.
Supernus Pharmaceuticals, Inc. and United Therapeutics Corp. appeal the entry of summary judgment by the U.S. District Court for the Eastern District of Virginia. The district court determined that, based on this court's decision in Gilead Sciences, Inc. v. Lee , the U.S. Patent and Trademark Office's calculation of the patent term adjustment for the patent at issue was correct, and that summary judgment was warranted as a matter of law. We reverse the district court's grant of summary judgment because the patent term adjustment in this case went beyond the period during…
2Cases cited19 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Consumer Product Safety Commission v. GTE Sylvania, Inc.Supreme Court of the United States · 1980
- National Cable & Telecommunications Assn. v. Brand X Internet ServicesSupreme Court of the United States · 2005
- Kelly v. RobinsonSupreme Court of the United States · 1986
- Pereira v. SessionsSupreme Court of the United States · 2018
14 more not listed; retrieve them via the Exa API.
3Cited by17 opinions
- Nippon Shinyaku Co. v. IancuCourt of Appeals for the D.C. Circuit · 2019
- Chudik v. HirshfeldCourt of Appeals for the Federal Circuit · 2021
- Intra-Cellular Therapies, Inc v. IancuCourt of Appeals for the Federal Circuit · 2019
- Thaler v. VidalCourt of Appeals for the Federal Circuit · 2022
- Sawstop Holding LLC v. VidalCourt of Appeals for the Federal Circuit · 2022
12 more not listed; retrieve them via the Exa API.